Drug recall · April 4, 2018
Fosphenytoin Sodium Injection recall
Why: Presence of particulate matter
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Fosphenytoin Sodium Injection, USP 500 mg PE*/10 mL, Made in India. Distributed by: Amneal Biosciences, Bridgewater, NJ 08807, NDC 70121-1390-1
- Lots / codes
Lot #: AP160022, AP160023, Exp. 05/2018; AP16038, AP160039, AP160040, Exp. 06/2018; AP160076, AP160077, AP160078, Exp. 12/2018
- Quantity
- 12,584 vials
- Company
- Amneal Pharmaceuticals, Brookhaven, NY
- Distribution
- U.S.A Nationwide
- Initiated
- December 15, 2017 · Voluntary: Firm initiated
- Classified
- March 29, 2018
- Reported
- April 4, 2018
- Ended
- August 3, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fosphenytoin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.